Clinical Trial Update: A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of a freeze-dried Group ACYW135 meningococcal conjugate vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Group ACYW135 Meningococcal Conjugate Vaccine (Meningococcal conjugate vaccine ACYW135)

Snippet

Sponsor: Lanzhou Institute of Biological Products Co., Ltd | Conditions: Meningococcal Meningitis | Phase 1 | Status: UNKNOWN